Genmab — Oktober 2018

[E_L]

only mention in Novartis financials: Phase III ASCLEPIOS studies fully
recruited and on track for 2019
readout (Ofa for MS)

[bibob]

Tak Helge.

[E_L]

Maybe if there is a way to see the questions asked by others, we can avoid putting duplicates in, that would make life easier for you? And if we number them, we can just tell you what number to delete if they become irrelevant? (just thinking outloud)

[Helge_LarsenPI-redaktør]

The same questions are not the big problem. It's more that I get the questions in the last minute. It does not give me enough time for editing.

[Raun]

De seneste par dages handel, kunne godt indikere at der bliver lukket shorts

[Helge_LarsenPI-redaktør]

EL. I think most people have noticed that I'm making reminders around to ask questions many days before Q & A.

[E_L]

yeah… including me.. ahum… #guilty

[Helge_LarsenPI-redaktør]

[E_L]

Immunotherapy can fire up a protein that disables a T cell attack https://www.mdanderson.org/publications/cancer-frontline/2018/august-2018/immunotherapy-fires-up-protein-on-tumors-that-supresses-immune-a.html

[E_L]

i dont't want to fire up the dara/pd(l)1 debate again, but the article is from august

[E_L]

i only find 1 MD Anderson bladder cancer trial with dara , but this one does not have a pd1 https://clinicaltrials.gov/ct2/show/NCT03473730?term=cd38+bladder+Anderson&rank=1

[Bulder]

It must be a new study to come. Dara in solids still alive. Good easy to understand article that repeats what we've heard ealier from Limo Chen.

[Bulder]

Good sign that they (MD A.) hasn't given up the thought and is willing to finance a new study.

[Bulder]

Well, they don't say that the cd38-drug will be dara. It's my interpretation.

[E_L]

i searched for cd38, this was the only one and it was dara. Let's hope you are correct and it will still come.

[Bulder]

They also have the old one from last year in presurgical prostate. But again without pd1.

[peter12]

@EL You posted this link first time 28/8 but ok

[peter12]

What about this study ? https://www.clinicaltrialsregister.eu/ctr-search/search?query=nivolumab+daratumumab&dateFrom=2017-01-01&dateTo=2018-10-18

[Bulder]

Det første er MM. Det andet er et af BMS-studierne, som der skulle komme data fra om ikke så længe.

[E_L]

I just wanted to make sure you read it peter